Account
MakeMyTrip appoints Isobar India as its digital partner
MUMBAI: MakeMyTrip has appointed Isobar India, a global full-service digital agency, from the Dentsu Aegis Network,as its digital agency, with the mandate to handle digital brand engagement and social media management duties.
Isobar India MD Shamsuddin Jasani said, “It’s a great achievement for us. Over the past few months, the team has worked diligently and passionately in making the brand’s recent campaigns a huge success. We are thrilled to work with the biggest and the most credible online travel agency in India.”
Isobar India VP Gopa Kumar added, “It’s a big privilege to be the digital partner for MakeMyTrip. The team is geared up to give their best and come up with exciting digital solutions for the brand in keeping with our focus on brand narratives leading up to brand commerce.”
MakeMyTrip.com, India’s leading online travel company was founded in the year 2000 by Deep Kalra. Today, it is much more than just a travel portal or a famous pioneering brand – it is a one-stop-travel-shop that offers the broadest selection of travel products and services in India. MakeMyTrip is the dominant market-leader with 47% market-share (PhocusWright, 2013), a fact evinced by the trust placed in it by millions of happy customers.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
